Literature DB >> 11595595

Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV).

M T Rugeles1, F Solano, F J Díaz, V I Bedoya, P J Patiño.   

Abstract

BACKGROUND: Both clinical and laboratory evidence in exposed seronegative (ESN) individuals to human HIV-1 has suggested the existence of mechanisms of natural resistance to the infection. A 32 base-pair deletion in the gene that codes for the CCR5, which is the main coreceptor for HIV-1, confers a high degree of resistance to HIV-1 infection. However, the genotype Delta32/Delta32 is present only in 2-4% of Caucasoid ESN individuals suggesting the existence of other mechanisms of protection. Mutations different from Delta32 have also been proposed as playing a role in resistance/susceptibility to this infection.
OBJECTIVE: To screen for different mutations along the entire coding region of the ccr5 gene that can potentially explain the persistent seronegativity in a group of ESN individuals. STUDY
DESIGN: Of a total of 86 individuals analyzed for Delta32 mutation by the PCR technique, 36 scored HIV seropositive (SP) and 50 were ESN. The entire group of ESN individuals was screened for other mutations in the ccr5 gene by single strand conformational polymorphism (SSCP) and DNA sequencing.
RESULTS: The frequency of the mutant allele Delta32 was 4% (4/100) for ESN individuals and 4.2% (3/72) for SP individuals. The homozygous mutant genotype (Delta32/Delta32) was found in only 2% (1/50) of ESN individuals, but in no SP individuals. The heterozygous genotype was found in 8.3% (3/36) of SP individuals and in 4% (2/50) of ESN individuals. The differences in the allelic and genotypic frequencies among the groups were not statistically significant. A comparison between the observed and the expected genotypic frequencies showed that they were significantly different for the ESN group, suggesting a protective, yet indirect effect of the mutant genotype.
CONCLUSIONS: The screening of the entire coding region of the ccr5 gene in all ESN did not revealed no other mutations that could account for resistance to HIV-1 infection. Although the CCR5 molecule is the most important coreceptor for HIV-1, mutations in this gene do not account for most of the cases of natural resistance to this virus that have so far been reported.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11595595     DOI: 10.1016/s1386-6532(01)00219-0

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.

Authors:  Wildeman Zapata; Wbeimar Aguilar-Jiménez; Nicolás Pineda-Trujillo; Winston Rojas; Hernando Estrada; María T Rugeles
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-09       Impact factor: 2.205

2.  Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals.

Authors:  Enrico M Trecarichi; Mario Tumbarello; Katleen de Gaetano Donati; Enrica Tamburrini; Roberto Cauda; Christina Brahe; Francesco D Tiziano
Journal:  AIDS Res Ther       Date:  2006-09-25       Impact factor: 2.250

3.  The CCR5-Delta32 Genetic Polymorphism and HIV-1 Infection Susceptibility: a Meta-analysis.

Authors:  Jun Ni; Dan Wang; Sheng Wang
Journal:  Open Med (Wars)       Date:  2018-10-16

4.  Cytokine Storm Combined with Humoral Immune Response Defect in Fatal Hemorrhagic Fever with Renal Syndrome Case, Tatarstan, Russia.

Authors:  Ekaterina Garanina; Ekaterina Martynova; Yuriy Davidyuk; Emmanuel Kabwe; Konstantin Ivanov; Angelina Titova; Maria Markelova; Margarita Zhuravleva; Georgiy Cherepnev; Venera G Shakirova; Ilseyar Khaertynova; Rachael Tarlinton; Albert Rizvanov; Svetlana Khaiboullina; Sergey Morzunov
Journal:  Viruses       Date:  2019-07-02       Impact factor: 5.048

5.  Δccr5 Genotype Is Associated with Mild Form of Nephropathia Epidemica.

Authors:  Konstantin Kletenkov; Ekaterina Martynova; Yuriy Davidyuk; Emmanuel Kabwe; Anton Shamsutdinov; Ekaterina Garanina; Venera Shakirova; Ilsiyar Khaertynova; Vladimir Anokhin; Rachael Tarlinton; Albert Rizvanov; Svetlana Khaiboullina; Sergey Morzunov
Journal:  Viruses       Date:  2019-07-23       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.